What is the onset time of Endone (oxycodone) in a patient with normal renal and hepatic function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onset Time of Endone (Oxycodone)

Oral oxycodone (Endone) has an onset of action of approximately 10-30 minutes, with peak analgesic effect occurring at 1 hour after administration in patients with normal renal and hepatic function. 1, 2

Route-Specific Onset Times

Oral Administration (Standard Formulation)

  • Immediate-release oral oxycodone begins producing clinical effects within 10-30 minutes of ingestion 1
  • Peak plasma concentration and maximal analgesic effect occur at approximately 1 hour (60 minutes) after oral administration 2
  • The duration of analgesic effect for immediate-release formulations is 3-6 hours 1

Controlled-Release Formulation

  • Controlled-release oxycodone (OxyContin) has a slower onset, with effects commencing approximately 1 hour after administration 2
  • Peak effect for controlled-release formulations occurs later but provides sustained analgesia for 10-12 hours 1, 2

Intravenous Administration

  • When given intravenously, oxycodone demonstrates significantly faster onset, though this route is less commonly used in routine practice 3
  • IV administration bypasses first-pass metabolism, resulting in more rapid onset compared to oral routes 3

Pharmacokinetic Considerations in Normal Function

  • Oral bioavailability ranges from 60-87%, which is substantially higher than morphine 2
  • Plasma half-life is 3-5 hours (approximately half that of morphine) 2
  • Stable plasma levels are reached within 24 hours, much faster than morphine which requires 2-7 days 2
  • Plasma protein binding is 45% 2

Clinical Comparison with Other Analgesics

  • In comparative studies, oral oxycodone at 0.125 mg/kg provided similar pain relief to IV morphine 0.1 mg/kg at 30 minutes after administration, though IV morphine showed faster onset at 10 and 20 minutes 4
  • The delayed onset of oral oxycodone compared to IV opioids is offset by easier administration and no requirement for IV access 4
  • Oral oxycodone demonstrates onset of analgesia at 30 minutes that is comparable to naproxen in soft tissue injury pain control 5

Important Clinical Caveats

  • The onset time represents when analgesic effects begin, not when peak analgesia is achieved - peak effect occurs at 1 hour 2
  • Tablets must be swallowed whole and must not be broken, chewed, or crushed, as this can alter the pharmacokinetic profile and potentially cause rapid release of the entire dose 2
  • There is no food interference with absorption 2
  • Metabolism is more predictable than morphine, making titration easier and more reliable 2

Special Populations Requiring Dose Adjustment

Hepatic Impairment

  • In patients with hepatic dysfunction, oxycodone demonstrates decreased intrinsic hepatic clearance due to reduced enzyme activity or intrahepatic shunting 1
  • Oral oxycodone should be initiated at lower doses in patients with liver disease 1
  • The bioavailability increases significantly in HCC patients (68%) compared to healthy individuals (17%) 1
  • Recent guidelines suggest avoiding oxycodone in patients with end-stage liver disease 1

Renal Impairment

  • Oxycodone is primarily eliminated in urine and should be carefully titrated with frequent monitoring in patients with renal impairment 1
  • The half-life may be prolonged in renal insufficiency, though less dramatically than morphine 1

Elderly Patients

  • No specific dose reduction is needed in the elderly for immediate-release formulations, though clinical monitoring remains essential 2
  • However, elderly patients may experience prolonged duration of effect due to altered pharmacokinetics 1

Safety Monitoring During Onset Period

  • Respiratory depression is the major adverse effect and can occur even at therapeutic doses, particularly when combined with benzodiazepines or other CNS depressants 1
  • Common side effects during the onset period include nausea (most common), constipation, drowsiness, with less frequent vomiting, pruritus, and dizziness 2, 5
  • Oxycodone causes somewhat less nausea, hallucinations, and pruritus compared to morphine 2
  • The intensity of side effects tends to decrease over time with continued use 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Research

Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.